Pregnancy outcomes after first trimester exposure to phentermine/fenfluramine

Teratology

Volumn 65, Issue 3, 2002, Pages 125-130

  Jones, Kenneth Lyons ^a,b   Johnson, Kathleen A ^a   Dick, Lyn M ^a   Felix, Robert J ^a   Kao, Kelly K ^a   Chambers, Christina D ^a  

^a UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^b UCSD MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FENFLURAMINE; PHENTERMINE;

ADULT; ARTICLE; BIRTH WEIGHT; CONTROLLED STUDY; FEMALE; FETUS DEVELOPMENT; FIRST TRIMESTER PREGNANCY; HEAD CIRCUMFERENCE; HUMAN; MAJOR CLINICAL STUDY; PARTHENOGENESIS; PREGNANCY COMPLICATION; PREGNANCY DIABETES MELLITUS; PREMATURE LABOR; PRENATAL DRUG EXPOSURE; PRIORITY JOURNAL; VALVULAR HEART DISEASE; WEIGHT REDUCTION;

ABNORMALITIES, DRUG-INDUCED; ABORTION, SPONTANEOUS; APPETITE DEPRESSANTS; COHORT STUDIES; DRUG THERAPY, COMBINATION; FEMALE; FENFLURAMINE; HUMANS; INFANT, NEWBORN; PHENTERMINE; PREGNANCY; PREGNANCY TRIMESTER, FIRST; PROSPECTIVE STUDIES;

EID: 0036187504     PISSN: 00403709     EISSN: None     Source Type: Journal    
DOI: 10.1002/tera.10023     Document Type: Article

References (17)

1. Effects of prenatal co-administration of phentermine and dexfenfluramine in rats
2. Postmarketing surveillance for human teratogenicity: A model approach
3. Valvular heart disease associated with fenfluramine-phentermine
4. Valvular abnormalities and cardiovascular status following exposure to dexfenfluramine or phentermine/fenfluramine
5. Toxicologic studies of fenfluramine
6. Further cases of valvular heart disease associated with fenfluramine-phentermine
7. Asymptomatic mitral and aortic valve disease is seen in half of the patients taking phen-fen
8. A population-based study of appetite-suppressant drugs and the risk of cardiac-valve regurgitation
9. The prevalence of cardiac valvular insufficiency assessed by transthoracic echocardiography in obese patients treated with appetite suppressant drugs
10. Dose-effect of fenfluramine use on the severity of valvular heart disease among fen-phen patients with valvulopathy
11. Congenital anomalies in the newborn infant, including minor variations: A study of 4,412 babies by surface examination for anomalies and buccal smears for sex chromatin
12. Impact of antenatal exposure to fenfluramine (Pondimin, Redux) on pregnancy and neonatal outcome in mice
13. Interim public health recommendations, Cardiac valvulopathy associated with exposure to fenfluramine or dexfenfluramine
14. First-trimester in utero exposure to anorectics: A French collaborative study with special reference to dexfenfluramine
15. Current status of teratology. General principles and mechanisms derived from animal studies